Cargando…

Serum amino acid concentrations and clinical outcomes in smokers: SPIROMICS metabolomics study

Metabolomics is an emerging science that can inform pathogenic mechanisms behind clinical phenotypes in COPD. We aimed to understand disturbances in the serum metabolome associated with respiratory outcomes in ever-smokers from the SPIROMICS cohort. We measured 27 serum metabolites, mostly amino aci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Labaki, Wassim W., Gu, Tian, Murray, Susan, Curtis, Jeffrey L., Yeomans, Larisa, Bowler, Russell P., Barr, R. Graham, Comellas, Alejandro P., Hansel, Nadia N., Cooper, Christopher B., Barjaktarevic, Igor, Kanner, Richard E., Paine, Robert, McDonald, Merry-Lynn N., Krishnan, Jerry A., Peters, Stephen P., Woodruff, Prescott G., O’Neal, Wanda K., Diao, Wenqi, He, Bei, Martinez, Fernando J., Standiford, Theodore J., Stringer, Kathleen A., Han, MeiLan K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6684630/ https://www.ncbi.nlm.nih.gov/pubmed/31388056 http://dx.doi.org/10.1038/s41598-019-47761-w

Ejemplares similares

Association of thrombocytosis with COPD morbidity: the SPIROMICS and COPDGene cohorts
por: Fawzy, Ashraf, et al.
Publicado: (2018)

Lower serum IgA is associated with COPD exacerbation risk in SPIROMICS
por: Putcha, Nirupama, et al.
Publicado: (2018)

Frequency of Exacerbations in COPD: An Analysis of the SPIROMICS Cohort
por: Han, MeiLan K., et al.
Publicado: (2017)

Novel Respiratory Disability Score Predicts COPD Exacerbations and Mortality in the SPIROMICS Cohort
por: Cooper, Christopher B, et al.
Publicado: (2020)

Association of plasma mitochondrial DNA with COPD severity and progression in the SPIROMICS cohort
por: Zhang, William Z., et al.
Publicado: (2021)

Increased airway iron parameters and risk for exacerbation in COPD: an analysis from SPIROMICS
por: Zhang, William Z., et al.
Publicado: (2020)

Defining Chronic Mucus Hypersecretion Using the CAT in the SPIROMICS Cohort
por: Stott-Miller, Marni, et al.
Publicado: (2020)

Lung microbiota associations with clinical features of COPD in the SPIROMICS cohort
por: Opron, Kristopher, et al.
Publicado: (2021)

Longitudinal Imaging-Based Clusters in Former Smokers of the COPD Cohort Associate with Clinical Characteristics: The SubPopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)
por: Zou, Chunrui, et al.
Publicado: (2021)

Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort Analysis
por: Barjaktarevic, Igor Z, et al.
Publicado: (2019)

Design of the Subpopulations and Intermediate Outcome Measures in COPD (SPIROMICS) AIR Study
por: Hansel, Nadia N, et al.
Publicado: (2017)

Imaging-based clusters in former smokers of the COPD cohort associate with clinical characteristics: the SubPopulations and intermediate outcome measures in COPD study (SPIROMICS)
por: Haghighi, Babak, et al.
Publicado: (2019)

Imaging-based clusters in current smokers of the COPD cohort associate with clinical characteristics: the SubPopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)
por: Haghighi, Babak, et al.
Publicado: (2018)

Centrilobular emphysema and coronary artery calcification: mediation analysis in the SPIROMICS cohort
por: Bhatt, Surya P., et al.
Publicado: (2018)

Sputum or blood eosinophil association with clinical measures of COPD severity in the SPIROMICS cohort
por: Hastie, AT, et al.
Publicado: (2017)

The matrikine acetyl-proline-glycine-proline and clinical features of COPD: findings from SPIROMICS
por: Wells, J. Michael, et al.
Publicado: (2019)

Black carbon content in airway macrophages is associated with increased severe exacerbations and worse COPD morbidity in SPIROMICS
por: Tejwani, Vickram, et al.
Publicado: (2022)

Comparison of serum, EDTA plasma and P100 plasma for luminex-based biomarker multiplex assays in patients with chronic obstructive pulmonary disease in the SPIROMICS study
por: O’Neal, Wanda K, et al.
Publicado: (2014)

Machine learning for screening of at-risk, mild and moderate COPD patients at risk of FEV(1) decline: results from COPDGene and SPIROMICS
por: Wang, Jennifer M., et al.
Publicado: (2023)

Latent traits of lung tissue patterns in former smokers derived by dual channel deep learning in computed tomography images
por: Li, Frank, et al.
Publicado: (2021)

Disruption of histidine and energy homeostasis in chronic obstructive pulmonary disease
por: Diao, Wenqi, et al.
Publicado: (2019)

Design of a multi-center immunophenotyping analysis of peripheral blood, sputum and bronchoalveolar lavage fluid in the Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)
por: Freeman, Christine M, et al.
Publicado: (2015)

A Metabolomic Severity Score for Airflow Obstruction and Emphysema
por: Godbole, Suneeta, et al.
Publicado: (2022)

Bronchoalveolar Lavage Fluid from COPD Patients Reveals More Compounds Associated with Disease than Matched Plasma
por: Halper-Stromberg, Eitan, et al.
Publicado: (2019)

Current smoking with or without chronic bronchitis is independently associated with goblet cell hyperplasia in healthy smokers and COPD subjects
por: Kim, Victor, et al.
Publicado: (2020)

A blood and bronchoalveolar lavage protein signature of rapid FEV(1) decline in smoking-associated COPD
por: DiLillo, Katarina M., et al.
Publicado: (2023)

Robust Measures of Image-Registration-Derived Lung Biomechanics in SPIROMICS
por: Pan, Yue, et al.
Publicado: (2022)

Correcting Nonpathological Variation in Longitudinal Parametric Response Maps of CT Scans in COPD Subjects: SPIROMICS
por: Fernández-Baldera, Antonio, et al.
Publicado: (2017)

The influence of social support on COPD outcomes mediated by depression
por: Turnier, Leonard, et al.
Publicado: (2021)

An airway epithelial IL-17A response signature identifies a steroid-unresponsive COPD patient subgroup
por: Christenson, Stephanie A., et al.
Publicado: (2018)

Impact of bronchiectasis on the frequency and severity of respiratory exacerbations in COPD
por: Labaki, Wassim W, et al.
Publicado: (2018)

Heterogeneous burden of lung disease in smokers with borderline airflow obstruction
por: Pirozzi, Cheryl S., et al.
Publicado: (2018)

Plasma metabolomics and quantitative interstitial abnormalities in ever-smokers
por: Choi, Bina, et al.
Publicado: (2023)

Chronic obstructive pulmonary disease risk assessment tools: is one better than the others?
por: Wang, Jennifer M., et al.
Publicado: (2022)

The value of blood cytokines and chemokines in assessing COPD
por: Bradford, Eric, et al.
Publicado: (2017)

Metabolomic Profiling Reveals Sex Specific Associations with Chronic Obstructive Pulmonary Disease and Emphysema
por: Gillenwater, Lucas A., et al.
Publicado: (2021)

Variability in objective and subjective measures affects baseline values in studies of patients with COPD
por: Anderson, Wayne H., et al.
Publicado: (2017)

Differentiation of quantitative CT imaging phenotypes in asthma versus COPD
por: Choi, Sanghun, et al.
Publicado: (2017)

The association of plasma biomarkers with computed tomography-assessed emphysema phenotypes
por: Carolan, Brendan J, et al.
Publicado: (2014)

Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort Analysis [Corrigendum]
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8dkt0l7v52iqnn0kncdu0v1aip